The family of the interleukin-1 receptors.

The extracellular forms of the IL-1 cytokines are active through binding to specific receptors on the surface of target cells. IL-1 ligands bind to the extracellular portion of their ligand binding receptor chain. For signalling to take place, a non-binding accessory chain is recruited into a hetero-trimeric complex. The intracellular approximation of the Toll-IL-1-receptor (TIR) domains of the two receptor chains is the event that initiates signalling. The family of IL-1 receptors (IL-1R) includes ten structurally related members, and the distantly related soluble protein IL-18BP that acts as inhibitor of the cytokine IL-18. Over the years the receptors of the IL-1 family have been known with many different names, with significant confusion. Thus, we will use here a recently proposed unifying nomenclature. The family includes several ligand-binding chains (IL-1R1, IL-1R2, IL-1R4, IL-1R5, IL-1R6), two types of accessory chains (IL-1R3, IL-1R7), molecules that act as inhibitors of signalling (IL-1R2, IL-1R8, IL-18BP), and two orphan receptors (IL-1R9, IL-1R10). In this review, we will examine how the receptors of the IL-1 family regulate the inflammatory and anti-inflammatory functions of the IL-1 cytokines and are, more at large, involved in modulating defensive and pathological innate immunity and inflammation. Regulation of the IL-1/IL-1R system in the brain will be also described, as an example of the peculiarities of organ-specific modulation of inflammation.